Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Rifaximin
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[8] 6, 65, 93, 96, 97, 99, 296, 299 💬
2Rifaximin 550 MG
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 6 💬
3Rifaximin 550 MG Oral Tablet [XIFAXAN]
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 299 💬
4Rifaximin Delayed Release (DR)
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 96 💬
5Rifaximin delayed release 400 mg film coated tablet
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 96 💬
6Rifaximin delayed release tablets
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 96 💬
7Rifaximin EIR
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 96 💬
8Rifaximin oral tablet
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 99 💬
9Rifaximin+omeprazole+miralax
(D02554)		[2] Omeprazole,
Rifaximin		[2] Omeprazole ,
Rifaximin (D02554) 💬		[2] ATP4A,
ATP4B 💬		[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 96 💬
10Rifaximin-EIR
(D02554)		[1] Rifaximin[1] Rifaximin (D02554) 💬--[1] 96 💬
11Sodium phosphate enema, oral rifaximin and polyethylene glycol
(D02554)		[3] Phosphate ion,
Polyethylene glycol,
Rifaximin		[2] Rifaximin (D02554),
Polyethylene glycol 3350 💬		--[1] 6 💬